Fusion Bacteriology Suite
AI-assisted bacteriology gram analysis for clinical labs
Software · Cloud SaaSCompany source
Company profile
About Techcyte
Techcyte is an AI software platform for anatomic and clinical pathology that leverages machine learning for quicker, more efficient diagnoses.
Company description Techcyte official website
Primary marketPathology & Laboratory Diagnostics
Commercial modelCommercial information available on request
Work at Techcyte?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Bacteriology
- Breast pathology
- Cervical cytology
- Cytology
- Dermatopathology
- Frozen section analysis
- GI pathology
- Hematology
- Non-GYN cytology
- Organ donation assessment
- Parasitology
- Prostate pathology
- Renal pathology
- Surgical pathology
Who it serves
- Academic institutions
- Environmental testing facilities
- Health systems
- Hospitals
- Pathology laboratories
- Veterinary labs
Deployment & integration
Cloud Saas · Hybrid deployment with recorded integration context.
Recorded integration context: 3DHistech/Epredia scanners, EHR, Grossing systems, Grundium Ocus 40, Hamamatsu scanners, Leica scanners, LIS, MetaSystems Metafer5, Motic scanners, Philips scanners, Pramana scanners, Radiology systems, Roche scanners.
Geographic context
MarketsEurope · United States
Company sourceOfficial website
Company milestones
Platform expansion
Fusion AP achieved CE-IVDR certification (2025). Unveiled Fusion unified anatomic and clinical digital pathology platform (March 2025). Multiple strategic partnerships announced 2024-2025 including Mayo Clinic Platform, BD, Deep Bio, Mindpeak, Aiosyn, Aiforia, Modella AI, and Pramana.
Partnerships
Recorded partners
- Aiforia (strategic collaboration, March 2025)
- Aiosyn (AI-powered slide QC and mitotic counting, March 2025)
- BD (Becton Dickinson) for cervical cytology system (February 2024)
- Deep Bio (AI-powered prostate diagnostics and frozen section, August 2025)
- Mayo Clinic Platform (strategic collaboration announced January 2024)
- Mindpeak (Fusion Partner Program, July 2025)
- Modella AI (research collaboration, August 2025)
- Pramana (scanner integration and edge AI, March 2025)
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Fusion Frozen Section Suite
Comprehensive digital workflow for frozen section labs with remote consultation
Platform · Cloud SaaSCompany source
Fusion Hematology Suite
Automated blood differential analysis for hematology workflows
Software · Cloud SaaSCompany source
Fusion Organ Donation Suite
Digital pathology solution for organ donation workflows
Software · Cloud SaaSCompany source
Fusion Parasitology Suite
AI-powered detection of protozoan and helminth parasites in stool samples
Software · Cloud SaaSCompany source
Techcyte Fusion AP
Unified anatomic pathology digital platform with AI-powered workflows
Platform · HybridCompany source
Techcyte SureView Cervical Cytology System
AI-based digital cervical cytology system
Software · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Detection of protozoan and helminth parasites in concentrated wet mounts of stool using a deep convolutional neural network.Journal of clinical microbiology · Nov 12, 2025
Implementing 100% quality control in a cervical cytology workflow using whole slide images and artificial intelligence provided by the Techcyte SureView™ System.Cancer cytopathology · Jun 1, 2025
Enhancing Organ Allocation Efficiency: A Pilot Study Evaluating Artificial Intelligence-Assisted Assessment of Donor Kidney Pathology.Cureus · May 1, 2025
Point-of-care platform integrated with deep-learning, convolutional neural network algorithms effectively evaluates canine and feline peripheral blood smears.American journal of veterinary research · Dec 20, 2024
Multicenter evaluation of the Vetscan Imagyst system using Ocus 40 and EasyScan One scanners to detect gastrointestinal parasites in feces of dogs and cats.Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc · Jan 1, 2024
A rapid and affordable point of care test for antibodies against SARS-CoV-2 based on hemagglutination and artificial intelligence interpretation.Scientific reports · Dec 30, 2021
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Faster turnaround times
Through streamlined digital workflows and AI-assisted diagnostics
Enhanced diagnostic accuracy
Via AI-powered image analysis and collaboration tools
Higher ROI for laboratories
Through workflow optimization and reduced manual tasks
Improved quality of care
Through unified platform and remote consultation capabilities
BD (Becton, Dickinson and Company)
Strategic collaboration to offer AI-based digital cervical cytology system
Mayo Clinic Platform
Strategic collaboration to transform the global practice of pathology through digital diagnostics
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Techcyte
Recent articles published on Techcyte's official website.
Techcyte in the news
Read on TechcyteTechcyte Named 2025 Infectious Disease Testing Solution of the Year by BioTech Breakthrough Awards
Read on TechcyteTechcyte Fusion Anatomic Pathology advances digital pathology transformation at Mayo Clinic
Read on TechcyteCytolab moves its cervical cytology screening to Techcyte SureView®
Read on TechcyteSchedule a Demo
Read on Techcyte07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Pathology & Laboratory Diagnostics
Companies applying AI to digital pathology, histopathology slide analysis, laboratory diagnostics, or biomarker discovery. Includes AI-powered interpretation of lab test results, at-home diagnostic devices with AI analysis, and platforms that analyze tissue samples or biological specimens to support clinical diagnosis.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.